Nursing aides plagued by PTSD after ‘nightmare’ covid conditions, with little help

One evening in May, nursing assistant Debra Ragoonanan’s vision blurred during her shift at a state-run Massachusetts veterans home.

Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis

An investigational Janus kinase 1 (JAK1) preferential inhibitor reduced the risk of treatment failure among patients with active noninfectious uveitis, the phase II randomized HUMBOLDT

July 20, 2024

Did Oregon’s Drug Decriminalization Policy Increase Overdose Deaths?

In this video interview, Brandon del Pozo, PhD, MPA, MA, of Rhode Island Hospital and Brown University in Providence, discusses his new article in JAMA

September 7, 2024

GSK to pay $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.